Compare with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PFIZER ALKEM LABORATORIES/
PFIZER
 
P/E (TTM) x - 36.5 - View Chart
P/BV x 7.2 6.2 116.2% View Chart
Dividend Yield % 0.6 0.6 109.2%  

Financials

 ALKEM LABORATORIES   PFIZER
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PFIZER
Mar-19
ALKEM LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,5893,840 41.4%   
Low Rs1,2322,080 59.2%   
Sales per share (Unadj.) Rs417.5455.0 91.8%  
Earnings per share (Unadj.) Rs56.393.8 60.0%  
Cash flow per share (Unadj.) Rs64.7109.4 59.2%  
Dividends per share (Unadj.) Rs12.7022.50 56.4%  
Dividend yield (eoy) %0.90.8 118.5%  
Book value per share (Unadj.) Rs292.9658.2 44.5%  
Shares outstanding (eoy) m119.5745.75 261.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.46.5 51.9%   
Avg P/E ratio x25.131.6 79.4%  
P/CF ratio (eoy) x21.827.1 80.6%  
Price / Book Value ratio x4.84.5 107.1%  
Dividend payout %22.624.0 94.0%   
Avg Mkt Cap Rs m168,653135,420 124.5%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m9,1713,238 283.2%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m49,91520,815 239.8%  
Other income Rs m1,6451,674 98.3%   
Total revenues Rs m51,56122,489 229.3%   
Gross profit Rs m8,4825,712 148.5%  
Depreciation Rs m1,006714 140.9%   
Interest Rs m67173 919.9%   
Profit before tax Rs m8,4516,599 128.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,309 69.6%   
Profit after tax Rs m6,7314,291 156.9%  
Gross profit margin %17.027.4 61.9%  
Effective tax rate %19.035.0 54.3%   
Net profit margin %13.520.6 65.4%  
BALANCE SHEET DATA
Current assets Rs m27,06227,167 99.6%   
Current liabilities Rs m15,3248,917 171.8%   
Net working cap to sales %23.587.7 26.8%  
Current ratio x1.83.0 58.0%  
Inventory Days Days6768 98.1%  
Debtors Days Days4130 137.1%  
Net fixed assets Rs m12,6108,862 142.3%   
Share capital Rs m239458 52.3%   
"Free" reserves Rs m34,49029,656 116.3%   
Net worth Rs m35,02730,113 116.3%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,38739,400 138.0%  
Interest coverage x13.691.5 14.9%   
Debt to equity ratio x00 4,166.6%  
Sales to assets ratio x0.90.5 173.7%   
Return on assets %13.611.1 122.9%  
Return on equity %19.214.2 134.9%  
Return on capital %24.922.1 112.3%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,563428 1,532.4%   
Fx outflow Rs m3,012786 383.0%   
Net fx Rs m3,552-358 -991.8%   
CASH FLOW
From Operations Rs m7,259978 742.1%  
From Investments Rs m1,864351 530.8%  
From Financial Activity Rs m-9,273-1,099 844.1%  
Net Cashflow Rs m-150231 -65.0%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 33.1 7.5 441.3%  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.7 -  
Shareholders   68,381 85,207 80.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  SUVEN LIFESCIENCES  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 18, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS